Controversies in breast cancer 2009
- PMID: 20030860
- PMCID: PMC2797681
- DOI: 10.1186/bcr2420
Controversies in breast cancer 2009
Similar articles
-
Lessons from 54 years of pharmaceutical research.Nat Rev Drug Discov. 2011 Oct 31;10(12):963. doi: 10.1038/nrd2961-c1. Nat Rev Drug Discov. 2011. PMID: 22036986 No abstract available.
-
Pharmaceutical sciences, scientists, and journals--a tribute to pharmaceutical research for its coming of age.Pharm Res. 2005 Feb;22(2):173-4. doi: 10.1007/s11095-004-1182-6. Pharm Res. 2005. PMID: 15783062 No abstract available.
-
Deal watch: Trends in platform technology deal-making.Nat Rev Drug Discov. 2009 Dec;8(12):923. doi: 10.1038/nrd3065. Nat Rev Drug Discov. 2009. PMID: 19949395 No abstract available.
-
Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group.Dis Markers. 1999 Oct;15(1-3):187-9. doi: 10.1155/1999/809015. Dis Markers. 1999. PMID: 10595276 Free PMC article. Review. No abstract available.
-
Management of women who have a genetic predisposition for breast cancer.Surg Clin North Am. 2008 Aug;88(4):845-61, vii-viii. doi: 10.1016/j.suc.2008.04.007. Surg Clin North Am. 2008. PMID: 18672143 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical